nodes	percent_of_prediction	percent_of_DWPC	metapath
Ezetimibe—SLCO1B1—Sulfasalazine—ankylosing spondylitis	0.116	0.131	CbGbCtD
Ezetimibe—ABCC2—Sulfasalazine—ankylosing spondylitis	0.102	0.115	CbGbCtD
Ezetimibe—ABCG2—Sulfasalazine—ankylosing spondylitis	0.0919	0.104	CbGbCtD
Ezetimibe—ABCC3—Methotrexate—ankylosing spondylitis	0.0897	0.102	CbGbCtD
Ezetimibe—ABCC2—Dexamethasone—ankylosing spondylitis	0.0507	0.0575	CbGbCtD
Ezetimibe—SLCO1B1—Methotrexate—ankylosing spondylitis	0.0464	0.0526	CbGbCtD
Ezetimibe—ABCG2—Dexamethasone—ankylosing spondylitis	0.0458	0.052	CbGbCtD
Ezetimibe—ABCB1—Methylprednisolone—ankylosing spondylitis	0.0437	0.0496	CbGbCtD
Ezetimibe—ABCC2—Methotrexate—ankylosing spondylitis	0.0408	0.0462	CbGbCtD
Ezetimibe—ABCG2—Methotrexate—ankylosing spondylitis	0.0368	0.0418	CbGbCtD
Ezetimibe—ABCB1—Betamethasone—ankylosing spondylitis	0.0284	0.0322	CbGbCtD
Ezetimibe—ABCB1—Prednisolone—ankylosing spondylitis	0.028	0.0318	CbGbCtD
Ezetimibe—ABCB1—Prednisone—ankylosing spondylitis	0.0265	0.03	CbGbCtD
Ezetimibe—CYP3A4—Methylprednisolone—ankylosing spondylitis	0.0262	0.0297	CbGbCtD
Ezetimibe—CYP3A4—Triamcinolone—ankylosing spondylitis	0.0198	0.0225	CbGbCtD
Ezetimibe—CYP3A4—Betamethasone—ankylosing spondylitis	0.017	0.0193	CbGbCtD
Ezetimibe—CYP3A4—Prednisolone—ankylosing spondylitis	0.0168	0.0191	CbGbCtD
Ezetimibe—ABCB1—Dexamethasone—ankylosing spondylitis	0.0165	0.0188	CbGbCtD
Ezetimibe—CYP3A4—Prednisone—ankylosing spondylitis	0.0159	0.018	CbGbCtD
Ezetimibe—ABCB1—Methotrexate—ankylosing spondylitis	0.0133	0.0151	CbGbCtD
Ezetimibe—CYP3A4—Dexamethasone—ankylosing spondylitis	0.0099	0.0112	CbGbCtD
Ezetimibe—Neuropathy peripheral—Prednisone—ankylosing spondylitis	0.000366	0.00308	CcSEcCtD
Ezetimibe—Breast disorder—Methotrexate—ankylosing spondylitis	0.000366	0.00308	CcSEcCtD
Ezetimibe—Malaise—Prednisolone—ankylosing spondylitis	0.000362	0.00305	CcSEcCtD
Ezetimibe—Back pain—Triamcinolone—ankylosing spondylitis	0.000357	0.00301	CcSEcCtD
Ezetimibe—Angiopathy—Betamethasone—ankylosing spondylitis	0.000349	0.00294	CcSEcCtD
Ezetimibe—Angiopathy—Dexamethasone—ankylosing spondylitis	0.000349	0.00294	CcSEcCtD
Ezetimibe—Hypertension—Prednisolone—ankylosing spondylitis	0.000346	0.00292	CcSEcCtD
Ezetimibe—Eosinophilia—Methotrexate—ankylosing spondylitis	0.000346	0.00292	CcSEcCtD
Ezetimibe—Pancreatitis—Methotrexate—ankylosing spondylitis	0.000343	0.00289	CcSEcCtD
Ezetimibe—Ill-defined disorder—Triamcinolone—ankylosing spondylitis	0.000342	0.00289	CcSEcCtD
Ezetimibe—Ill-defined disorder—Methylprednisolone—ankylosing spondylitis	0.000341	0.00288	CcSEcCtD
Ezetimibe—Alopecia—Betamethasone—ankylosing spondylitis	0.00034	0.00286	CcSEcCtD
Ezetimibe—Alopecia—Dexamethasone—ankylosing spondylitis	0.00034	0.00286	CcSEcCtD
Ezetimibe—Discomfort—Prednisolone—ankylosing spondylitis	0.000337	0.00284	CcSEcCtD
Ezetimibe—Angioedema—Triamcinolone—ankylosing spondylitis	0.000337	0.00284	CcSEcCtD
Ezetimibe—Angioedema—Methylprednisolone—ankylosing spondylitis	0.000336	0.00284	CcSEcCtD
Ezetimibe—Erythema—Betamethasone—ankylosing spondylitis	0.000335	0.00282	CcSEcCtD
Ezetimibe—Erythema—Dexamethasone—ankylosing spondylitis	0.000335	0.00282	CcSEcCtD
Ezetimibe—Malaise—Triamcinolone—ankylosing spondylitis	0.000333	0.0028	CcSEcCtD
Ezetimibe—Malaise—Methylprednisolone—ankylosing spondylitis	0.000332	0.0028	CcSEcCtD
Ezetimibe—Connective tissue disorder—Prednisone—ankylosing spondylitis	0.000329	0.00277	CcSEcCtD
Ezetimibe—Anaphylactic shock—Prednisolone—ankylosing spondylitis	0.000327	0.00276	CcSEcCtD
Ezetimibe—Upper respiratory tract infection—Methotrexate—ankylosing spondylitis	0.000325	0.00274	CcSEcCtD
Ezetimibe—Erectile dysfunction—Methotrexate—ankylosing spondylitis	0.000322	0.00271	CcSEcCtD
Ezetimibe—Cough—Triamcinolone—ankylosing spondylitis	0.000322	0.00271	CcSEcCtD
Ezetimibe—Photosensitivity reaction—Methotrexate—ankylosing spondylitis	0.000319	0.00269	CcSEcCtD
Ezetimibe—Hypertension—Triamcinolone—ankylosing spondylitis	0.000318	0.00268	CcSEcCtD
Ezetimibe—Hypertension—Methylprednisolone—ankylosing spondylitis	0.000318	0.00268	CcSEcCtD
Ezetimibe—Myalgia—Triamcinolone—ankylosing spondylitis	0.000314	0.00265	CcSEcCtD
Ezetimibe—Arthralgia—Methylprednisolone—ankylosing spondylitis	0.000313	0.00264	CcSEcCtD
Ezetimibe—Myalgia—Methylprednisolone—ankylosing spondylitis	0.000313	0.00264	CcSEcCtD
Ezetimibe—Infestation NOS—Methotrexate—ankylosing spondylitis	0.000312	0.00263	CcSEcCtD
Ezetimibe—Infestation—Methotrexate—ankylosing spondylitis	0.000312	0.00263	CcSEcCtD
Ezetimibe—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—ankylosing spondylitis	0.000311	0.00262	CcSEcCtD
Ezetimibe—Flushing—Prednisone—ankylosing spondylitis	0.000311	0.00262	CcSEcCtD
Ezetimibe—Ill-defined disorder—Dexamethasone—ankylosing spondylitis	0.000311	0.00262	CcSEcCtD
Ezetimibe—Ill-defined disorder—Betamethasone—ankylosing spondylitis	0.000311	0.00262	CcSEcCtD
Ezetimibe—Discomfort—Triamcinolone—ankylosing spondylitis	0.00031	0.00262	CcSEcCtD
Ezetimibe—Discomfort—Methylprednisolone—ankylosing spondylitis	0.00031	0.00261	CcSEcCtD
Ezetimibe—Dry mouth—Triamcinolone—ankylosing spondylitis	0.000307	0.00259	CcSEcCtD
Ezetimibe—Angioedema—Dexamethasone—ankylosing spondylitis	0.000306	0.00258	CcSEcCtD
Ezetimibe—Angioedema—Betamethasone—ankylosing spondylitis	0.000306	0.00258	CcSEcCtD
Ezetimibe—Angiopathy—Prednisone—ankylosing spondylitis	0.000304	0.00256	CcSEcCtD
Ezetimibe—Confusional state—Methylprednisolone—ankylosing spondylitis	0.000303	0.00255	CcSEcCtD
Ezetimibe—Immune system disorder—Prednisone—ankylosing spondylitis	0.000302	0.00255	CcSEcCtD
Ezetimibe—Malaise—Dexamethasone—ankylosing spondylitis	0.000302	0.00254	CcSEcCtD
Ezetimibe—Malaise—Betamethasone—ankylosing spondylitis	0.000302	0.00254	CcSEcCtD
Ezetimibe—Anaphylactic shock—Triamcinolone—ankylosing spondylitis	0.000301	0.00254	CcSEcCtD
Ezetimibe—Anaphylactic shock—Methylprednisolone—ankylosing spondylitis	0.0003	0.00253	CcSEcCtD
Ezetimibe—Infection—Triamcinolone—ankylosing spondylitis	0.000299	0.00252	CcSEcCtD
Ezetimibe—Infection—Methylprednisolone—ankylosing spondylitis	0.000298	0.00252	CcSEcCtD
Ezetimibe—Insomnia—Prednisolone—ankylosing spondylitis	0.000296	0.0025	CcSEcCtD
Ezetimibe—Alopecia—Prednisone—ankylosing spondylitis	0.000296	0.00249	CcSEcCtD
Ezetimibe—Hepatobiliary disease—Methotrexate—ankylosing spondylitis	0.000295	0.00249	CcSEcCtD
Ezetimibe—Nervous system disorder—Methylprednisolone—ankylosing spondylitis	0.000295	0.00248	CcSEcCtD
Ezetimibe—Paraesthesia—Prednisolone—ankylosing spondylitis	0.000294	0.00248	CcSEcCtD
Ezetimibe—Mental disorder—Prednisone—ankylosing spondylitis	0.000293	0.00247	CcSEcCtD
Ezetimibe—Skin disorder—Methylprednisolone—ankylosing spondylitis	0.000292	0.00246	CcSEcCtD
Ezetimibe—Erythema—Prednisone—ankylosing spondylitis	0.000291	0.00246	CcSEcCtD
Ezetimibe—Malnutrition—Prednisone—ankylosing spondylitis	0.000291	0.00246	CcSEcCtD
Ezetimibe—Hypertension—Betamethasone—ankylosing spondylitis	0.000289	0.00244	CcSEcCtD
Ezetimibe—Hypertension—Dexamethasone—ankylosing spondylitis	0.000289	0.00244	CcSEcCtD
Ezetimibe—Myalgia—Betamethasone—ankylosing spondylitis	0.000285	0.0024	CcSEcCtD
Ezetimibe—Myalgia—Dexamethasone—ankylosing spondylitis	0.000285	0.0024	CcSEcCtD
Ezetimibe—Discomfort—Dexamethasone—ankylosing spondylitis	0.000282	0.00237	CcSEcCtD
Ezetimibe—Discomfort—Betamethasone—ankylosing spondylitis	0.000282	0.00237	CcSEcCtD
Ezetimibe—Pain—Prednisolone—ankylosing spondylitis	0.00028	0.00236	CcSEcCtD
Ezetimibe—Hepatitis—Methotrexate—ankylosing spondylitis	0.00028	0.00236	CcSEcCtD
Ezetimibe—Pharyngitis—Methotrexate—ankylosing spondylitis	0.000278	0.00234	CcSEcCtD
Ezetimibe—Musculoskeletal discomfort—Triamcinolone—ankylosing spondylitis	0.000274	0.00231	CcSEcCtD
Ezetimibe—Musculoskeletal discomfort—Methylprednisolone—ankylosing spondylitis	0.000274	0.00231	CcSEcCtD
Ezetimibe—Anaphylactic shock—Dexamethasone—ankylosing spondylitis	0.000273	0.0023	CcSEcCtD
Ezetimibe—Anaphylactic shock—Betamethasone—ankylosing spondylitis	0.000273	0.0023	CcSEcCtD
Ezetimibe—Insomnia—Triamcinolone—ankylosing spondylitis	0.000272	0.0023	CcSEcCtD
Ezetimibe—Insomnia—Methylprednisolone—ankylosing spondylitis	0.000272	0.00229	CcSEcCtD
Ezetimibe—Infection—Betamethasone—ankylosing spondylitis	0.000271	0.00229	CcSEcCtD
Ezetimibe—Infection—Dexamethasone—ankylosing spondylitis	0.000271	0.00229	CcSEcCtD
Ezetimibe—Ill-defined disorder—Prednisone—ankylosing spondylitis	0.00027	0.00228	CcSEcCtD
Ezetimibe—Paraesthesia—Triamcinolone—ankylosing spondylitis	0.00027	0.00228	CcSEcCtD
Ezetimibe—Feeling abnormal—Prednisolone—ankylosing spondylitis	0.00027	0.00227	CcSEcCtD
Ezetimibe—Paraesthesia—Methylprednisolone—ankylosing spondylitis	0.00027	0.00227	CcSEcCtD
Ezetimibe—Anaemia—Prednisone—ankylosing spondylitis	0.000269	0.00227	CcSEcCtD
Ezetimibe—Dyspnoea—Triamcinolone—ankylosing spondylitis	0.000268	0.00226	CcSEcCtD
Ezetimibe—Nervous system disorder—Dexamethasone—ankylosing spondylitis	0.000268	0.00226	CcSEcCtD
Ezetimibe—Nervous system disorder—Betamethasone—ankylosing spondylitis	0.000268	0.00226	CcSEcCtD
Ezetimibe—Thrombocytopenia—Betamethasone—ankylosing spondylitis	0.000267	0.00225	CcSEcCtD
Ezetimibe—Thrombocytopenia—Dexamethasone—ankylosing spondylitis	0.000267	0.00225	CcSEcCtD
Ezetimibe—Angioedema—Prednisone—ankylosing spondylitis	0.000266	0.00225	CcSEcCtD
Ezetimibe—Dyspepsia—Triamcinolone—ankylosing spondylitis	0.000265	0.00223	CcSEcCtD
Ezetimibe—Erythema multiforme—Methotrexate—ankylosing spondylitis	0.000265	0.00223	CcSEcCtD
Ezetimibe—Dyspepsia—Methylprednisolone—ankylosing spondylitis	0.000264	0.00223	CcSEcCtD
Ezetimibe—Malaise—Prednisone—ankylosing spondylitis	0.000263	0.00222	CcSEcCtD
Ezetimibe—Urticaria—Prednisolone—ankylosing spondylitis	0.00026	0.00219	CcSEcCtD
Ezetimibe—Fatigue—Triamcinolone—ankylosing spondylitis	0.00026	0.00219	CcSEcCtD
Ezetimibe—Fatigue—Methylprednisolone—ankylosing spondylitis	0.000259	0.00218	CcSEcCtD
Ezetimibe—Pain—Triamcinolone—ankylosing spondylitis	0.000257	0.00217	CcSEcCtD
Ezetimibe—Angiopathy—Methotrexate—ankylosing spondylitis	0.000254	0.00214	CcSEcCtD
Ezetimibe—Immune system disorder—Methotrexate—ankylosing spondylitis	0.000253	0.00213	CcSEcCtD
Ezetimibe—Mediastinal disorder—Methotrexate—ankylosing spondylitis	0.000252	0.00213	CcSEcCtD
Ezetimibe—Hypertension—Prednisone—ankylosing spondylitis	0.000252	0.00212	CcSEcCtD
Ezetimibe—Musculoskeletal discomfort—Betamethasone—ankylosing spondylitis	0.000249	0.0021	CcSEcCtD
Ezetimibe—Musculoskeletal discomfort—Dexamethasone—ankylosing spondylitis	0.000249	0.0021	CcSEcCtD
Ezetimibe—Myalgia—Prednisone—ankylosing spondylitis	0.000248	0.00209	CcSEcCtD
Ezetimibe—Arthralgia—Prednisone—ankylosing spondylitis	0.000248	0.00209	CcSEcCtD
Ezetimibe—Feeling abnormal—Triamcinolone—ankylosing spondylitis	0.000248	0.00209	CcSEcCtD
Ezetimibe—Feeling abnormal—Methylprednisolone—ankylosing spondylitis	0.000248	0.00209	CcSEcCtD
Ezetimibe—Alopecia—Methotrexate—ankylosing spondylitis	0.000247	0.00208	CcSEcCtD
Ezetimibe—Insomnia—Dexamethasone—ankylosing spondylitis	0.000247	0.00208	CcSEcCtD
Ezetimibe—Insomnia—Betamethasone—ankylosing spondylitis	0.000247	0.00208	CcSEcCtD
Ezetimibe—Unspecified disorder of skin and subcutaneous tissue—Prednisone—ankylosing spondylitis	0.000246	0.00208	CcSEcCtD
Ezetimibe—Gastrointestinal pain—Methylprednisolone—ankylosing spondylitis	0.000246	0.00207	CcSEcCtD
Ezetimibe—Paraesthesia—Betamethasone—ankylosing spondylitis	0.000245	0.00207	CcSEcCtD
Ezetimibe—Paraesthesia—Dexamethasone—ankylosing spondylitis	0.000245	0.00207	CcSEcCtD
Ezetimibe—Discomfort—Prednisone—ankylosing spondylitis	0.000245	0.00207	CcSEcCtD
Ezetimibe—Mental disorder—Methotrexate—ankylosing spondylitis	0.000245	0.00207	CcSEcCtD
Ezetimibe—Erythema—Methotrexate—ankylosing spondylitis	0.000244	0.00205	CcSEcCtD
Ezetimibe—Malnutrition—Methotrexate—ankylosing spondylitis	0.000244	0.00205	CcSEcCtD
Ezetimibe—Hypersensitivity—Prednisolone—ankylosing spondylitis	0.000241	0.00203	CcSEcCtD
Ezetimibe—Dyspepsia—Dexamethasone—ankylosing spondylitis	0.00024	0.00203	CcSEcCtD
Ezetimibe—Dyspepsia—Betamethasone—ankylosing spondylitis	0.00024	0.00203	CcSEcCtD
Ezetimibe—Urticaria—Triamcinolone—ankylosing spondylitis	0.000239	0.00202	CcSEcCtD
Ezetimibe—Urticaria—Methylprednisolone—ankylosing spondylitis	0.000239	0.00201	CcSEcCtD
Ezetimibe—Body temperature increased—Triamcinolone—ankylosing spondylitis	0.000238	0.00201	CcSEcCtD
Ezetimibe—Anaphylactic shock—Prednisone—ankylosing spondylitis	0.000238	0.00201	CcSEcCtD
Ezetimibe—Abdominal pain—Methylprednisolone—ankylosing spondylitis	0.000237	0.002	CcSEcCtD
Ezetimibe—Decreased appetite—Dexamethasone—ankylosing spondylitis	0.000237	0.002	CcSEcCtD
Ezetimibe—Decreased appetite—Betamethasone—ankylosing spondylitis	0.000237	0.002	CcSEcCtD
Ezetimibe—Infection—Prednisone—ankylosing spondylitis	0.000236	0.00199	CcSEcCtD
Ezetimibe—Gastrointestinal disorder—Dexamethasone—ankylosing spondylitis	0.000236	0.00199	CcSEcCtD
Ezetimibe—Gastrointestinal disorder—Betamethasone—ankylosing spondylitis	0.000236	0.00199	CcSEcCtD
Ezetimibe—Back pain—Methotrexate—ankylosing spondylitis	0.000236	0.00199	CcSEcCtD
Ezetimibe—Fatigue—Dexamethasone—ankylosing spondylitis	0.000235	0.00199	CcSEcCtD
Ezetimibe—Fatigue—Betamethasone—ankylosing spondylitis	0.000235	0.00199	CcSEcCtD
Ezetimibe—Pain—Betamethasone—ankylosing spondylitis	0.000234	0.00197	CcSEcCtD
Ezetimibe—Pain—Dexamethasone—ankylosing spondylitis	0.000234	0.00197	CcSEcCtD
Ezetimibe—Nervous system disorder—Prednisone—ankylosing spondylitis	0.000233	0.00197	CcSEcCtD
Ezetimibe—Skin disorder—Prednisone—ankylosing spondylitis	0.000231	0.00195	CcSEcCtD
Ezetimibe—Ill-defined disorder—Methotrexate—ankylosing spondylitis	0.000226	0.00191	CcSEcCtD
Ezetimibe—Anaemia—Methotrexate—ankylosing spondylitis	0.000225	0.0019	CcSEcCtD
Ezetimibe—Feeling abnormal—Dexamethasone—ankylosing spondylitis	0.000225	0.0019	CcSEcCtD
Ezetimibe—Feeling abnormal—Betamethasone—ankylosing spondylitis	0.000225	0.0019	CcSEcCtD
Ezetimibe—Gastrointestinal pain—Betamethasone—ankylosing spondylitis	0.000223	0.00188	CcSEcCtD
Ezetimibe—Gastrointestinal pain—Dexamethasone—ankylosing spondylitis	0.000223	0.00188	CcSEcCtD
Ezetimibe—Hypersensitivity—Triamcinolone—ankylosing spondylitis	0.000222	0.00187	CcSEcCtD
Ezetimibe—Hypersensitivity—Methylprednisolone—ankylosing spondylitis	0.000221	0.00187	CcSEcCtD
Ezetimibe—Malaise—Methotrexate—ankylosing spondylitis	0.00022	0.00185	CcSEcCtD
Ezetimibe—Urticaria—Betamethasone—ankylosing spondylitis	0.000217	0.00183	CcSEcCtD
Ezetimibe—Urticaria—Dexamethasone—ankylosing spondylitis	0.000217	0.00183	CcSEcCtD
Ezetimibe—Musculoskeletal discomfort—Prednisone—ankylosing spondylitis	0.000217	0.00183	CcSEcCtD
Ezetimibe—Dizziness—Prednisolone—ankylosing spondylitis	0.000216	0.00183	CcSEcCtD
Ezetimibe—Asthenia—Triamcinolone—ankylosing spondylitis	0.000216	0.00182	CcSEcCtD
Ezetimibe—Abdominal pain—Dexamethasone—ankylosing spondylitis	0.000216	0.00182	CcSEcCtD
Ezetimibe—Abdominal pain—Betamethasone—ankylosing spondylitis	0.000216	0.00182	CcSEcCtD
Ezetimibe—Body temperature increased—Betamethasone—ankylosing spondylitis	0.000216	0.00182	CcSEcCtD
Ezetimibe—Body temperature increased—Dexamethasone—ankylosing spondylitis	0.000216	0.00182	CcSEcCtD
Ezetimibe—Asthenia—Methylprednisolone—ankylosing spondylitis	0.000216	0.00182	CcSEcCtD
Ezetimibe—Insomnia—Prednisone—ankylosing spondylitis	0.000215	0.00181	CcSEcCtD
Ezetimibe—Paraesthesia—Prednisone—ankylosing spondylitis	0.000214	0.0018	CcSEcCtD
Ezetimibe—Pruritus—Triamcinolone—ankylosing spondylitis	0.000213	0.0018	CcSEcCtD
Ezetimibe—Cough—Methotrexate—ankylosing spondylitis	0.000213	0.00179	CcSEcCtD
Ezetimibe—Pruritus—Methylprednisolone—ankylosing spondylitis	0.000213	0.00179	CcSEcCtD
Ezetimibe—Dyspepsia—Prednisone—ankylosing spondylitis	0.000209	0.00177	CcSEcCtD
Ezetimibe—Myalgia—Methotrexate—ankylosing spondylitis	0.000207	0.00175	CcSEcCtD
Ezetimibe—Chest pain—Methotrexate—ankylosing spondylitis	0.000207	0.00175	CcSEcCtD
Ezetimibe—Arthralgia—Methotrexate—ankylosing spondylitis	0.000207	0.00175	CcSEcCtD
Ezetimibe—Decreased appetite—Prednisone—ankylosing spondylitis	0.000207	0.00174	CcSEcCtD
Ezetimibe—Rash—Prednisolone—ankylosing spondylitis	0.000206	0.00174	CcSEcCtD
Ezetimibe—Dermatitis—Prednisolone—ankylosing spondylitis	0.000206	0.00174	CcSEcCtD
Ezetimibe—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—ankylosing spondylitis	0.000206	0.00174	CcSEcCtD
Ezetimibe—Diarrhoea—Methylprednisolone—ankylosing spondylitis	0.000206	0.00173	CcSEcCtD
Ezetimibe—Fatigue—Prednisone—ankylosing spondylitis	0.000205	0.00173	CcSEcCtD
Ezetimibe—Headache—Prednisolone—ankylosing spondylitis	0.000205	0.00173	CcSEcCtD
Ezetimibe—Discomfort—Methotrexate—ankylosing spondylitis	0.000205	0.00173	CcSEcCtD
Ezetimibe—Constipation—Prednisone—ankylosing spondylitis	0.000203	0.00171	CcSEcCtD
Ezetimibe—Confusional state—Methotrexate—ankylosing spondylitis	0.0002	0.00169	CcSEcCtD
Ezetimibe—Dizziness—Triamcinolone—ankylosing spondylitis	0.000199	0.00168	CcSEcCtD
Ezetimibe—Anaphylactic shock—Methotrexate—ankylosing spondylitis	0.000199	0.00168	CcSEcCtD
Ezetimibe—Dizziness—Methylprednisolone—ankylosing spondylitis	0.000199	0.00167	CcSEcCtD
Ezetimibe—Infection—Methotrexate—ankylosing spondylitis	0.000198	0.00167	CcSEcCtD
Ezetimibe—Feeling abnormal—Prednisone—ankylosing spondylitis	0.000196	0.00165	CcSEcCtD
Ezetimibe—Asthenia—Betamethasone—ankylosing spondylitis	0.000196	0.00165	CcSEcCtD
Ezetimibe—Asthenia—Dexamethasone—ankylosing spondylitis	0.000196	0.00165	CcSEcCtD
Ezetimibe—Nervous system disorder—Methotrexate—ankylosing spondylitis	0.000195	0.00164	CcSEcCtD
Ezetimibe—Thrombocytopenia—Methotrexate—ankylosing spondylitis	0.000195	0.00164	CcSEcCtD
Ezetimibe—Gastrointestinal pain—Prednisone—ankylosing spondylitis	0.000195	0.00164	CcSEcCtD
Ezetimibe—Nausea—Prednisolone—ankylosing spondylitis	0.000194	0.00164	CcSEcCtD
Ezetimibe—Pruritus—Betamethasone—ankylosing spondylitis	0.000193	0.00163	CcSEcCtD
Ezetimibe—Pruritus—Dexamethasone—ankylosing spondylitis	0.000193	0.00163	CcSEcCtD
Ezetimibe—Skin disorder—Methotrexate—ankylosing spondylitis	0.000193	0.00163	CcSEcCtD
Ezetimibe—Vomiting—Triamcinolone—ankylosing spondylitis	0.000191	0.00161	CcSEcCtD
Ezetimibe—Vomiting—Methylprednisolone—ankylosing spondylitis	0.000191	0.00161	CcSEcCtD
Ezetimibe—Rash—Triamcinolone—ankylosing spondylitis	0.00019	0.0016	CcSEcCtD
Ezetimibe—Dermatitis—Triamcinolone—ankylosing spondylitis	0.00019	0.0016	CcSEcCtD
Ezetimibe—Rash—Methylprednisolone—ankylosing spondylitis	0.000189	0.0016	CcSEcCtD
Ezetimibe—Dermatitis—Methylprednisolone—ankylosing spondylitis	0.000189	0.0016	CcSEcCtD
Ezetimibe—Urticaria—Prednisone—ankylosing spondylitis	0.000189	0.00159	CcSEcCtD
Ezetimibe—Headache—Triamcinolone—ankylosing spondylitis	0.000189	0.00159	CcSEcCtD
Ezetimibe—Headache—Methylprednisolone—ankylosing spondylitis	0.000188	0.00159	CcSEcCtD
Ezetimibe—Abdominal pain—Prednisone—ankylosing spondylitis	0.000188	0.00159	CcSEcCtD
Ezetimibe—Body temperature increased—Prednisone—ankylosing spondylitis	0.000188	0.00159	CcSEcCtD
Ezetimibe—Diarrhoea—Dexamethasone—ankylosing spondylitis	0.000187	0.00158	CcSEcCtD
Ezetimibe—Diarrhoea—Betamethasone—ankylosing spondylitis	0.000187	0.00158	CcSEcCtD
Ezetimibe—Musculoskeletal discomfort—Methotrexate—ankylosing spondylitis	0.000181	0.00153	CcSEcCtD
Ezetimibe—Dizziness—Dexamethasone—ankylosing spondylitis	0.000181	0.00152	CcSEcCtD
Ezetimibe—Dizziness—Betamethasone—ankylosing spondylitis	0.000181	0.00152	CcSEcCtD
Ezetimibe—Insomnia—Methotrexate—ankylosing spondylitis	0.00018	0.00152	CcSEcCtD
Ezetimibe—Nausea—Triamcinolone—ankylosing spondylitis	0.000179	0.00151	CcSEcCtD
Ezetimibe—Paraesthesia—Methotrexate—ankylosing spondylitis	0.000179	0.00151	CcSEcCtD
Ezetimibe—Nausea—Methylprednisolone—ankylosing spondylitis	0.000178	0.0015	CcSEcCtD
Ezetimibe—Dyspnoea—Methotrexate—ankylosing spondylitis	0.000177	0.00149	CcSEcCtD
Ezetimibe—Hypersensitivity—Prednisone—ankylosing spondylitis	0.000175	0.00148	CcSEcCtD
Ezetimibe—Dyspepsia—Methotrexate—ankylosing spondylitis	0.000175	0.00148	CcSEcCtD
Ezetimibe—Vomiting—Dexamethasone—ankylosing spondylitis	0.000174	0.00146	CcSEcCtD
Ezetimibe—Vomiting—Betamethasone—ankylosing spondylitis	0.000174	0.00146	CcSEcCtD
Ezetimibe—Decreased appetite—Methotrexate—ankylosing spondylitis	0.000173	0.00146	CcSEcCtD
Ezetimibe—Rash—Betamethasone—ankylosing spondylitis	0.000172	0.00145	CcSEcCtD
Ezetimibe—Rash—Dexamethasone—ankylosing spondylitis	0.000172	0.00145	CcSEcCtD
Ezetimibe—Dermatitis—Betamethasone—ankylosing spondylitis	0.000172	0.00145	CcSEcCtD
Ezetimibe—Dermatitis—Dexamethasone—ankylosing spondylitis	0.000172	0.00145	CcSEcCtD
Ezetimibe—Gastrointestinal disorder—Methotrexate—ankylosing spondylitis	0.000172	0.00145	CcSEcCtD
Ezetimibe—Fatigue—Methotrexate—ankylosing spondylitis	0.000171	0.00145	CcSEcCtD
Ezetimibe—Headache—Dexamethasone—ankylosing spondylitis	0.000171	0.00144	CcSEcCtD
Ezetimibe—Headache—Betamethasone—ankylosing spondylitis	0.000171	0.00144	CcSEcCtD
Ezetimibe—Asthenia—Prednisone—ankylosing spondylitis	0.000171	0.00144	CcSEcCtD
Ezetimibe—Pain—Methotrexate—ankylosing spondylitis	0.00017	0.00143	CcSEcCtD
Ezetimibe—Pruritus—Prednisone—ankylosing spondylitis	0.000168	0.00142	CcSEcCtD
Ezetimibe—Feeling abnormal—Methotrexate—ankylosing spondylitis	0.000164	0.00138	CcSEcCtD
Ezetimibe—Diarrhoea—Prednisone—ankylosing spondylitis	0.000163	0.00137	CcSEcCtD
Ezetimibe—Gastrointestinal pain—Methotrexate—ankylosing spondylitis	0.000163	0.00137	CcSEcCtD
Ezetimibe—Nausea—Betamethasone—ankylosing spondylitis	0.000162	0.00137	CcSEcCtD
Ezetimibe—Nausea—Dexamethasone—ankylosing spondylitis	0.000162	0.00137	CcSEcCtD
Ezetimibe—Urticaria—Methotrexate—ankylosing spondylitis	0.000158	0.00133	CcSEcCtD
Ezetimibe—Dizziness—Prednisone—ankylosing spondylitis	0.000157	0.00133	CcSEcCtD
Ezetimibe—Abdominal pain—Methotrexate—ankylosing spondylitis	0.000157	0.00132	CcSEcCtD
Ezetimibe—Body temperature increased—Methotrexate—ankylosing spondylitis	0.000157	0.00132	CcSEcCtD
Ezetimibe—Vomiting—Prednisone—ankylosing spondylitis	0.000151	0.00128	CcSEcCtD
Ezetimibe—Rash—Prednisone—ankylosing spondylitis	0.00015	0.00126	CcSEcCtD
Ezetimibe—Dermatitis—Prednisone—ankylosing spondylitis	0.00015	0.00126	CcSEcCtD
Ezetimibe—Headache—Prednisone—ankylosing spondylitis	0.000149	0.00126	CcSEcCtD
Ezetimibe—Hypersensitivity—Methotrexate—ankylosing spondylitis	0.000146	0.00123	CcSEcCtD
Ezetimibe—Asthenia—Methotrexate—ankylosing spondylitis	0.000143	0.0012	CcSEcCtD
Ezetimibe—Nausea—Prednisone—ankylosing spondylitis	0.000141	0.00119	CcSEcCtD
Ezetimibe—Pruritus—Methotrexate—ankylosing spondylitis	0.000141	0.00119	CcSEcCtD
Ezetimibe—Diarrhoea—Methotrexate—ankylosing spondylitis	0.000136	0.00115	CcSEcCtD
Ezetimibe—Dizziness—Methotrexate—ankylosing spondylitis	0.000131	0.00111	CcSEcCtD
Ezetimibe—Vomiting—Methotrexate—ankylosing spondylitis	0.000126	0.00107	CcSEcCtD
Ezetimibe—Rash—Methotrexate—ankylosing spondylitis	0.000125	0.00106	CcSEcCtD
Ezetimibe—Dermatitis—Methotrexate—ankylosing spondylitis	0.000125	0.00106	CcSEcCtD
Ezetimibe—Headache—Methotrexate—ankylosing spondylitis	0.000125	0.00105	CcSEcCtD
Ezetimibe—Nausea—Methotrexate—ankylosing spondylitis	0.000118	0.000996	CcSEcCtD
